Belite Bio, Inc: updates and filings

BLTENASDAQHealthcare · Pharmaceutical Preparations

Price

$127.38

November 20, 2026Market cap $5.0B

What Ploutos Investor adds for Belite Bio

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 6 fiscal years, from 2020
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Mar 31, 2026 latest annual
  • Nov 20, 2026Current report (foreign company)
    Form6-K
  • Nov 12, 2026Current report (foreign company)
    Form6-K
  • Oct 19, 2026Current report (foreign company)
    Form6-K
  • Sep 8, 2026Current report (foreign company)
    Form6-K
  • Aug 13, 2026Current report (foreign company)
    Form6-K
  • Aug 11, 2026Current report (foreign company)
    Form6-K
  • Jun 15, 2026Current report (foreign company)
    Form6-K
  • May 20, 2026Current report (foreign company)
    Form6-K
  • May 14, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Apr 21, 2026Current report (foreign company)
    Form6-K
  • Mar 31, 2026Current report (foreign company)
    Form6-K
  • Mar 31, 2026Annual report (foreign company)for the period to Dec 31, 2025
    Form20-F
  • Mar 2, 2026Current report (foreign company)
    Form6-K
  • Feb 17, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Jan 30, 2026Shares registered for employees
    FormS-8
  • Jan 27, 2026Current report (foreign company)
    Form6-K
  • Dec 10, 2025Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Dec 2, 2025Current report (foreign company)
    Form6-K
  • Dec 1, 2025Current report (foreign company)
    Form6-K
  • Dec 1, 2025Current report (foreign company)
    Form6-K
  • Dec 1, 2025Current report (foreign company)
    Form6-K
  • Nov 10, 2025Current report (foreign company)
    Form6-K
  • Oct 22, 2025Filing
    FormF-3ASR
  • Sep 8, 2025Current report (foreign company)
    Form6-K
  • Aug 11, 2025Current report (foreign company)
    Form6-K

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Dec 1, 2021.

The full analysis

What do Belite Bio's filings show?

The filings are where every one of Belite Bio's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.